NeueHealth, Inc. (NYSE:NEUE – Get Free Report) CAO Jeffrey J. Scherman sold 1,368 shares of NeueHealth stock in a transaction that occurred on Monday, January 6th. The stock was sold at an average price of $7.33, for a total transaction of $10,027.44. Following the completion of the transaction, the chief accounting officer now owns 5,942 shares in the company, valued at approximately $43,554.86. This trade represents a 18.71 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.
NeueHealth Trading Up 0.7 %
NYSE NEUE opened at $7.45 on Thursday. NeueHealth, Inc. has a 1 year low of $3.79 and a 1 year high of $16.59. The company has a market cap of $61.72 million, a PE ratio of -0.15 and a beta of 0.57. The stock’s 50-day moving average price is $5.51 and its two-hundred day moving average price is $5.39.
Institutional Investors Weigh In On NeueHealth
A number of large investors have recently made changes to their positions in NEUE. Renaissance Technologies LLC acquired a new position in NeueHealth in the 2nd quarter worth approximately $312,000. Partners Group Holding AG acquired a new stake in NeueHealth during the 3rd quarter valued at $463,000. Deer Management Co. LLC purchased a new stake in shares of NeueHealth in the second quarter valued at $5,436,000. Finally, NEA Management Company LLC acquired a new stake in shares of NeueHealth in the second quarter worth $14,834,000. Institutional investors and hedge funds own 63.88% of the company’s stock.
Analyst Ratings Changes
Read Our Latest Report on NeueHealth
About NeueHealth
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Read More
- Five stocks we like better than NeueHealth
- What is the Dow Jones Industrial Average (DJIA)?
- Why AMD Stock Might Already Be This Year’s Best Buy
- Insider Trades May Not Tell You What You Think
- 3 Promising Penny Stocks to Watch for Long-Term Gains in 2025
- Quiet Period Expirations Explained
- The 3 Kings of Buybacks in 2024: Can They Do It Again?
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.